Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody persistence after childhood REVAXIS or DT Polio vaccination and booster response to TETRAVAC-ACELLULAIRE
2011-004458-25Phase 4
- Sponsor
- Sanofi
- Start
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Quadracel in diphtheria, Tetanus, poliomyelitis and 1 more (2 arms), sponsored by Sanofi. Primary endpoint: Antibody persistence.
02
Drugs
Quadracel
03
Conditions
diphtheriaTetanuspoliomyelitispertussis
Beyond the preview
Go deeper on 2011-004458-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004458-25.